Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late. Shares of the ...

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing hair-loss ...

Founded in 2018, Defiance is at the forefront of ETF innovation. Defiance is a leading ETF issuer specializing in thematic, ...

Hims and other telehealth companies make finasteride easy to get and don’t have to disclose side effects in ads.

We had a good time talking to folks last week in our ColorTokens booth at the Healthcare Information and Management Systems ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

Believe it or not, there's something worse than male pattern baldness. It's depression, plunging libido and shrinking genitals. Those are the symptoms doct ...

As healthcare organizations consider artificial intelligence adoption, it’s imperative that they are using accurate, quality ...

But as the drugstore chain (WBA) prepares to go private and its rival CVS Health Inc. (CVS) experiments with smaller stores, some analysts and researchers see a possible future with even fewer ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

The second group, so-called "Constrained Losers," are those hard-to-short stocks that have lost the most over the trailing year. The professors found that these stocks also lag the market, but for a ...

Discover how Chicago-based Humboldt Park Health is utilizing AI tools to save millions of dollars annually and improve patient care, as told by an executive.